Rentschler Biopharma to purchase US manufacturing site from Shire

Under the terms of the agreement, Rentschler Biopharma will continue to manufacture product for Shire at the site

Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA, USA.

The development and manufacturing site will be leveraged as a CDMO by Rentschler Biopharma.

The closing of the transaction is subject to the prior satisfaction or waiver of certain closing conditions.

Financial terms of the transaction were not disclosed.